BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29447955)

  • 1. PTH (1-34) affects bone turnover governed by osteocytes exposed to fluoride.
    Yu X; Yu H; Jiang N; Zhang X; Zhang M; Xu H
    Toxicol Lett; 2018 May; 288():25-34. PubMed ID: 29447955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluoride on osteocyte-driven osteoclastic differentiation.
    Jiang N; Guo F; Xu W; Zhang Z; Jin H; Shi L; Zhang X; Gao J; Xu H
    Toxicology; 2020 Apr; 436():152429. PubMed ID: 32156525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
    Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
    J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.
    Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E
    J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
    Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL
    J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
    J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIKs control osteocyte responses to parathyroid hormone.
    Wein MN; Liang Y; Goransson O; Sundberg TB; Wang J; Williams EA; O'Meara MJ; Govea N; Beqo B; Nishimori S; Nagano K; Brooks DJ; Martins JS; Corbin B; Anselmo A; Sadreyev R; Wu JY; Sakamoto K; Foretz M; Xavier RJ; Baron R; Bouxsein ML; Gardella TJ; Divieti-Pajevic P; Gray NS; Kronenberg HM
    Nat Commun; 2016 Oct; 7():13176. PubMed ID: 27759007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
    Allison H; Holdsworth G; McNamara LM
    BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen alone or in combination with parathyroid hormone can decrease vertebral MEF2 and sclerostin expression and increase vertebral bone mass in ovariectomized rats.
    Jia HB; Ma JX; Ma XL; Yu JT; Feng R; Xu LY; Wang J; Xing D; Zhu SW; Wang Y
    Osteoporos Int; 2014 Dec; 25(12):2743-54. PubMed ID: 25074352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST.
    Silvestrini G; Ballanti P; Sebastiani M; Leopizzi M; Di Vito M; Bonucci E
    J Mol Histol; 2008 Apr; 39(2):237-42. PubMed ID: 18158586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
    Ben-awadh AN; Delgado-Calle J; Tu X; Kuhlenschmidt K; Allen MR; Plotkin LI; Bellido T
    Endocrinology; 2014 Aug; 155(8):2797-809. PubMed ID: 24877630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H; Guo J; Bringhurst FR
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
    Li C; Wang W; Xie L; Luo X; Cao X; Wan M
    Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.
    Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F
    Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.
    Fujiwara M; Kubota T; Wang W; Ohata Y; Miura K; Kitaoka T; Okuzaki D; Namba N; Michigami T; Kitabatake Y; Ozono K
    Bone; 2016 Apr; 85():91-8. PubMed ID: 26851122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.